Sep 2026· Journal of Nuclear Medicine· Vol 67, pp. 1771 - 1776· 0 citations· 35 references
Medicine
TL;DR
The dynamic changes of CD163-positive TAMs in HNSCC progression and treatment response were determined to assess the potential of a CD163 targeted radiotracer, 64Cu-ICT-01, in detecting CD163-positive TAMs for translation in HNSCC.
Abstract
Visual Abstract Tumor-associated macrophages (TAMs) are an important component of the tumor microenvironment (TME). The abundance and distribution of TAMs significantly affect the immune responses of TME to determine the tumor progression and treatment response of solid tumors such as head and neck squamous cell carcinoma (HNSCC). Molecular characterization of human HNSCC specimens and mouse models has identified CD163 as a unique biomarker for TAMs in HNSCC. The goal of this study was to determine the dynamic changes of CD163-positive TAMs in HNSCC progression and treatment response to assess the potential of a CD163 targeted radiotracer, 64Cu-ICT-01, in detecting CD163-positive TAMs for translation in HNSCC. Methods: We assessed the capability of 64Cu-ICT-01 for noninvasive imaging of CD163-positive TAMs using PET. We determined its targeting specificity in multiple mouse HNSCC models to track the progression of tumors. We assessed its sensitivity in tracking variations of CD163-positive TAMs and correlation with tumor volumes after clinical treatment. We also measured its binding to CD163-positive TAMs upregulated on human HNSCC tissues. Results: 64Cu-ICT-01 PET specifically determined the spatiotemporal distribution of CD163-positive TAMs in a MOC1 cell line model and patient-derived xenograft HNSCC models. CD163 PET sensitively tracked the dynamics of CD163-positive TAMs after clinical treatment. Its tumor binding correlated with CD163 expression levels and the volumes of tumors. In human HNSCC specimens, 64Cu-ICT-01 showed strong and specific binding to human CD163. Conclusion: 64Cu-ICT-01 demonstrated accurate targeting of CD163 in both mouse tumor models and human HNSCC tissues. CD163 PET has great potential to be a noninvasive biomarker to measure TAM activities within TME, monitor treatment response, and optimize treatment strategy.
Imaging tumor-associated macrophages (TAMs) may reflect prognosis, therapeutic response and radiotheranostic potential. We report the discovery and development of a synthetic human Fab as the first immunoPET tracer targeting human CD68 (huCD68), the gold standard histopathological biomarker of pan-macrophages. Phage di...
Borna Roohani, Ayla Vaughn Embs, Robin Kumar et al.· European Journal of Nuclear...· 0 citations
Abstract Tumor-associated macrophages (TAMs) are among the most abundant immune cells in the lung cancer tumor microenvironment (TME), where their functions vary according to developmental origin, local signals, metabolic conditions, spatial location, and treatment exposure. The conventional M1 and M2 framework therefo...
Jia-Cheng Sun, Ying Liu, Hua-Lin Sun et al.· Drug Design, Development and...· 0 citations
Brain metastases (BrM) exhibit variable intracranial responses to immune checkpoint blockade (ICB), and reliable biomarkers of benefit remain uncertain, possibly reflecting the distinctive brain microenvironment. This review discusses multiplex protein imaging, array-based spatial transcriptomics, and in situ RNA imagi...
Studies on the dynamic changes occurring in the tumor microenvironment (TME) following CAR-T cell therapy have been confounded by host lymphodepletion, multiple dosing and immunodeficient models. Therefore, CAR-T cell mediated changes in the TME contributing to solid tumor resistance to CAR-T cell therapy remain poor...
Abstract An orthotopically xenografted mouse GL26 glioma model (Ccr2RFP/wt-Cx3cr1GFP/wt) was used to evaluate the effect of transient, focal opening of the Blood Brain Barrier (BBB) on the composition of tumor-associated macrophages and microglia (TAMs). Opening of the BBB was induced by Magnetic Resonance Imaging (MRI...
Yan-Rong Zhang, Jing Wang, Sara Natasha Ghobadi et al.· Research Square· 0 citations